Suyaash Pharmaceuticals

Pharmacovigilance

Pharmacovigilance

Drug safety starts with every report

If you experience or observe a suspected adverse event involving a medicinal product manufactured by Suyaash Pharmaceuticals, please tell our Pharmacovigilance team. Your report can help us monitor product safety and protect patients.

Medical emergencyThis mailbox is not an emergency service. If urgent medical help is needed, contact a doctor or emergency service immediately.
1

Download the form

Open the PDF form and save or print a copy.

2

Add the details

Complete as much information as you can. You may still report when some details are unavailable.

3

Email your report

Attach the completed form and relevant supporting documents to your email.

What is an adverse event?

An adverse event is an unwanted or unexpected medical occurrence that happens while a person is using a medicinal product. A report does not need to prove that the product caused the event.

Who can report?

Patients, caregivers, doctors, pharmacists and other healthcare professionals may submit a report.

What should you include?

  • Patient details that help identify the case without unnecessary personal information
  • Product name, strength, batch number and how it was used
  • A description of the event, relevant dates and outcome
  • Your contact information so the team can request follow-up details

Why report?

Every report adds to the safety information available for a product. It helps the Pharmacovigilance team review patterns, request follow-up information and take appropriate action when needed.

Submit your report

Download the form, complete it and email it to the Suyaash Pharmaceuticals Pharmacovigilance team. You can also include prescriptions, laboratory results or discharge summaries that are relevant to the event.

Email completed form topharmacovigilancesuyaash@gmail.com

Privacy and confidentiality

Information is requested to assess and follow up the reported safety concern. Personal information will be handled confidentially for pharmacovigilance and applicable reporting responsibilities.